Cardiometabolic aging: A vicious cycle that must be broken: Editorial Article

Kazemi, Toba

doi:10.61882/JBUMS.33.1

Volume 33 - Supplement (Cardiometabolic) J Transl Med Res. 2026, 33 - Supplement (Cardiometabolic): 1-4 | Back to browse issues page

‎ 10.61882/JBUMS.33.1

Mendeley

Zotero

RefWorks

Kazemi T. Cardiometabolic aging: A vicious cycle that must be broken: Editorial Article. J Transl Med Res. 2026; 33 :1-4
URL: http://journal.bums.ac.ir/article-1-3582-en.html

Cardiometabolic aging: A vicious cycle that must be broken: Editorial Article

Toba Kazemi ^*

Cardiovascular Diseases Research Center, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran , drtooba.kazemi@gmail.com

Abstract: (576 Views)

Cardiometabolic aging is an emerging concept that describes a bidirectional interaction between metabolic disorders and biological aging processes. Evidences indicate that insulin resistance, central obesity, and dyslipidemia are not merely consequences of aging but they are active drivers of accelerated cellular aging. These metabolic disturbances promote a vicious cycle through the amplification of systemic chronic inflammation, oxidative stress, mitochondrial dysfunction, and adverse alterations in gut microbiota composition. These mechanisms accelerate biological aging, contribute to multimorbidity, and increase the risk of atherosclerotic cardiovascular diseases. This cycle is further intensified by unhealthy lifestyle, genetic and epigenetic susceptibility, and social health inequalities, making cardiometabolic aging a major contributor to the global burden of non‑communicable diseases (NCD). Breaking this cycle requires a paradigm shift from disease‑centered care toward early prevention, integrated lifestyle interventions, and equitable health policies across the life course.

Keywords: Abdominal obesity, Cardiometabolic aging, Insulin resistance, Non communicable diseases

Full-Text [PDF 317 kb] (203 Downloads)

Type of Study: Editorial | Subject: Cardiology
Received: 2026/01/10 | Accepted: 2026/02/28 | ePublished: 2026/03/6

References

1. Sarkar S, Prasanna VS, Das P, Suzuki H, Fujihara K, Kodama S, et al. The onset and the development of cardiometabolic aging: an insight into the underlying mechanisms. Front Pharmacol. 2024 Sep 26;15:1447890. DOI: 10.3389/fphar.2024.1447890 [DOI:10.3389/fphar.2024.1447890] [PMID] [PMCID]

2. Zhang K, Ma Y, Luo Y, Song Y, Xiong G, Ma Y, et al. Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health. Front Public Health. 2023 Oct 13;11:1253506.DOI: 10.3389/fpubh.2023.1253506 [DOI:10.3389/fpubh.2023.1253506] [PMID] [PMCID]

3. Emami M, Agbaedeng TA, Thomas G, Middeldorp ME, Thiyagarajah A, Wong CX, et al. Accelerated biological aging secondary to cardiometabolic risk factors is a predictor of cardiovascular mortality: a systematic review and meta-analysis. Can J Cardiol. 2022;38(3):365-75. DOI: 10.1016/j.cjca.2021.10.012 [DOI:10.1016/j.cjca.2021.10.012] [PMID]

4. Xu S, Liu Y, Zhu M, Chen K, Xu F, Liu Y. Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks. Sci China Life Sci. 2025; 68(9):2739-54. DOI: 10.1007/s11427-025-2948-y [DOI:10.1007/s11427-025-2948-y] [PMID]

5. Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):190. DOI: 10.1038/s41392-025-02253-4 [DOI:10.1038/s41392-025-02253-4] [PMID] [PMCID]

6. Wei P, Zhang X, Yan C, Sun S, Chen Z, Lin F. Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies. Biogerontology. 2025;26(4):142. DOI: 10.1007/s10522-025-10273-4 [DOI:10.1007/s10522-025-10273-4] [PMID] [PMCID]

7. Piłot M, Dzięgielewska-Gęsiak S, Walkiewicz KW, Bednarczyk M, Waniczek D, Muc-Wierzgoń M. Gut Microbiota and Metabolic Dysregulation in Elderly Diabetic Patients: Is There a Gender-Specific Effect. J Clin Med. 2025;14(9):3103. DOI: I10.3390/jcm14093103 [DOI:10.3390/jcm14093103] [PMID] [PMCID]

8. Hawker PJ, Bellamy J, Wong TY, McHugh C, Ward P, Wood A, et al. Effectiveness of lifestyle interventions for preventing or managing the adverse cardiometabolic and other physical health effects of antipsychotic medications in children and adolescents: systematic review and meta-analysis. BJPsych Open. 2026;12(1):e21. DOI:10.1192/bjo.2025.10919 [DOI:10.1192/bjo.2025.10919] [PMID] [PMCID]

9. Manfredi L, Buscema F, Giraudo MT, Sodano B, Padroni L, Destefanis C, et al. Does lifestyle explain the relationship between socioeconomic position and multimorbidity of cancer and cardiometabolic diseases? A mediation analysis applied to the European Prospective Investigation into Cancer and Nutrition. J Epidemiol Community Health. 2026;80(1):3-9. DOI: 10.1136/jech-2025-224476 [DOI:10.1136/jech-2025-224476] [PMID] [PMCID]

10. Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DM. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018 Apr 1;3(4):280-7. DOI: 10.1001/jamacardio.2018.0022 [DOI:10.1001/jamacardio.2018.0022] [PMID] [PMCID]